Literature DB >> 9158776

A transferable multiple drug resistance plasmid from Vibrio cholerae O1.

H Kruse1, H Sørum, F C Tenover, O Olsvik.   

Abstract

Ten multiple antimicrobial-resistant isolates of Vibrio cholerae O1 isolated from patients in Uganda were characterized, and the transferability of resistance to bacteria of diverse origins was investigated. The isolates were toxigenic and belonged to biotype E1 Tor, serotype Ogawa, and ribotype 8, and possessed a 130-MDa plasmid of incompatibility group 6-C. This plasmid, designated pRVC1, was shown to confer resistance to trimethoprim (mediated by a dhfrI gene), sulfonamides (a suII gene), tetracycline [a tet(C) gene], chloramphenicol (a catI gene), ampicillin (a beta-lactamase gene other than blaTEM or blaSHV), and streptomycin. pRVC1 proved to be transmissible at frequencies between 1 x 10(-1) and 5 x 10(-6) transconjugants per recipient to a variety of bacterial pathogens, including those of humans, animals, and fish. Most efficient transfer was observed from V. cholerae to strains of Shigella flexneri, Escherichia coli, Vibrio parahaemolyticus, and three Aeromonas species. The present in vitro study suggests that pRVC1 may spread from V. cholerae to other bacteria pathogenic to man, animals, and fish in natural environments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9158776     DOI: 10.1089/mdr.1995.1.203

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina.

Authors:  Alejandro Petroni; Alejandra Corso; Roberto Melano; María Luisa Cacace; Ana María Bru; Alicia Rossi; Marcelo Galas
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids.

Authors:  Jing-Cao Pan; Rong Ye; Hao-Qiu Wang; Hai-Qing Xiang; Wei Zhang; Xin-Fen Yu; Dong-Mei Meng; Zhe-Sheng He
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

Review 3.  Antimicrobials & cholera: are we stranded?

Authors:  Amit Ghosh; T Ramamurthy
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

4.  Development of pVCR94ΔX from Vibrio cholerae, a prototype for studying multidrug resistant IncA/C conjugative plasmids.

Authors:  Nicolas Carraro; Maxime Sauvé; Dominick Matteau; Guillaume Lauzon; Sébastien Rodrigue; Vincent Burrus
Journal:  Front Microbiol       Date:  2014-02-06       Impact factor: 5.640

5.  Identifying hotspots for antibiotic resistance emergence and selection, and elucidating pathways to human exposure: Application of a systems-thinking approach to aquaculture systems.

Authors:  Lucy A Brunton; Andrew P Desbois; Maria Garza; Barbara Wieland; Chadag Vishnumurthy Mohan; Barbara Häsler; Clarence C Tam; Phuc Nguyen Thien Le; Nguyen Thanh Phuong; Phan Thi Van; Hung Nguyen-Viet; Mahmoud M Eltholth; Dang Kim Pham; Phuc Pham Duc; Nguyen Tuong Linh; Karl M Rich; Ana L P Mateus; Md Ahasanul Hoque; Abdul Ahad; Mohammed Nurul Absar Khan; Alexandra Adams; Javier Guitian
Journal:  Sci Total Environ       Date:  2019-06-11       Impact factor: 7.963

6.  Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element.

Authors:  Japheth A Opintan; Mercy J Newman; Owusu Agyemang Nsiah-Poodoh; Iruka N Okeke
Journal:  J Antimicrob Chemother       Date:  2008-08-27       Impact factor: 5.790

7.  The burden of cholera in Uganda.

Authors:  Godfrey Bwire; Mugagga Malimbo; Brian Maskery; Young Eun Kim; Vittal Mogasale; Ann Levin
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.